Found 70 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

Accepts healthy volunteer
All genders
Observational
This study investigates the effects of an investigational vaccine on pregnancy outcomes. The study focuses on exposure to the vaccine during pregnancy.The study evaluates various outcomes related to maternal health, obstetrical events, and infant development. It focuses on understanding the effects of the investigational vaccine on both mothers and their …
18 years or above
All genders
Observational
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP).The study evaluates treatment outcomes for individuals with CIDP who have been on standard care for at least three months.Who can participate: Adults aged 18 and older with a neurologist-confirmed diagnosis of CIDP who have been using specific CIDP treatments for three months …
1 year or above
All genders
Observational
This study investigates eosinophilic esophagitis. It seeks to gather information about patients who are starting treatment with an investigational medication as part of their standard care.The study focuses on understanding how this treatment is used in everyday settings. It evaluates how the condition affects patients' feelings, symptoms, quality of life, …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates relapsed or refractory myeloma. It evaluates the effects of an investigational medication when combined with other novel agents, with or without dexamethasone.The study focuses on understanding the safety and effectiveness of these combinations in managing the condition. It evaluates how well the investigational medication works in different …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates advanced solid tumors. The purpose of this study is to explore the effects of an investigational medication in adults with these conditions.The study evaluates the safety and preliminary effectiveness of the investigational medication, both alone and in combination with other cancer treatments. It looks at how the …
2 years - 5 years
All genders
Phase 3
Interventional
This study investigates asthma and asthmatic wheeze in children aged 2 to under 6 years. The purpose of this study is to evaluate the effects of an investigational medication on these conditions.The study focuses on understanding the safety and effectiveness of the investigational medication over a long period. Researchers will …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates moderate to severe acne. The purpose of this study is to evaluate the safety, efficacy, and immunogenicity of an investigational mRNA vaccine for acne.The study evaluates how well the investigational vaccine works and its safety for participants. It also looks at the body's immune response to the …
18 years or above
All genders
Phase 1
Interventional
This study investigates the condition of relapsed/refractory myeloma. It focuses on understanding more about this condition through the use of an investigational medication.The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. It looks at how well participants tolerate the medication and its overall …
18 years or above
Accepts healthy volunteer
Male
Phase 3
This study investigates the use of tadalafil for erectile dysfunction. The purpose of this study is to see if participants can choose and use tadalafil appropriately based on product labeling and a health survey.The study evaluates how well participants can follow instructions for using tadalafil safely and effectively. It looks …
10 years - 65 years
All genders
Phase 3
Interventional
This study investigates sickle-cell disease. It focuses on understanding the effects of an investigational medication on people with this condition.The study evaluates the safety and effectiveness of the investigational medication. Researchers are interested in how well participants tolerate the treatment.Who can participate: Participants aged 10 to 65 years with sickle-cell …